Healthcare >> Analyst Interviews >> October 23, 2015
Donald Hooker, CFA, is a Vice President, Equity Research Analyst with KeyBanc Capital Markets Inc. With the company since 2013, his research coverage is focused on health care IT, biopharmaceuticals and laboratory companies. Prior to joining KBCM, Mr. Hooker worked at Morgan Stanley as a Research Analyst covering the health care information sector. Previous equity research experience includes working as a health care services, IT and facilities analyst for UBS Securities. Mr. Hooker graduated from the College of Wooster with a Bachelor of Arts in economics. He is a Chartered Financial Analyst and holds the Series 7, 63, 86 and 87 industry licenses. Mr. Hooker is also a member of the CFA Institute and the New York Society of Security Analysts — NYSSA. In its May 2016 Analyst Awards, Thomson Reuters recognized Mr. Hooker as the number one stock picker in the life science tools and services sector. This was Mr. Hooker’s second Thomson Reuters Analyst Award. In 2008, Mr. Hooker was recognized by The Wall Street Journal’s Best on the Street survey in the HCIT category. Profile
TWST: There has been a lot of activity in health IT over the last couple of years. Are things settling down now?
Mr. Hooker: Things have settled down somewhat,